HARBIN GLORIA PHARMACEUTICALS Co., LTD

¥2.99As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002437Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.82%)
Div yield —
ROE 16.23%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.27
PE TTM 17.43
TSR TTM (12.06%)
Mkt cap ¥6.667B
ROIC 15.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3.60
20.36%
(87.78%)
Hold 2|6|1|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.04
0.04
0.04
22.96%
25.22%
30.37%
30.83%
Revenue¥M
511.7
524.9
551.8
553.2
1.74%
5.77%
7.64%
4.91%
Peers (US$999.4M)
Cap (US$)
PE
1.003B
—
996.4M
30.31x
1.008B
—
Capital
TTM
5Y
10Y
Leveragex
3.479
0.542
0.593
EBIT/Intx
0.449
0.766
0.765
Own earn%
44.45
(82.02)
(71.42)
Sh yield%
16.31
40.53
40.48
Owners
Insiders/Inst%
10.29
78.73
Short interest%
0.67
SBC / revenue%
4.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
9–13
$1 testx
0.2
Incr. ROIC%
4